Michael Van Guilder
Impact in
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Statistical Methods and Bayesian Inference 5
- Statistical Methods in Clinical Trials 5
- Co-authors
- Alan Schumitzky (10 shared papers)Roger W. Jelliffe (9 shared papers)David S. Bayard (6 shared papers)Michael Neely (5 shared papers)Pascal Maire (4 shared papers)Walter M. Yamada (1 shared paper)Emi Minejima (1 shared paper)Brenda Jones (1 shared paper)
- Journals
- Therapeutic Drug Monitoring (7 papers)Antimicrobial Agents and Chemotherapy (3 papers)Clinical Pharmacokinetics (2 papers)Statistics in Medicine (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesFranceMexico
In The Last Decade
Michael Van Guilder
15 papers receiving 847 citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Pharmacology 481
- Clinical Biochemistry 149
- Applied Microbiology and Biotechnology 39
- Infectious Diseases 334
- Molecular Medicine 70
Countries citing papers authored by Michael Van Guilder
This map shows the geographic impact of Michael Van Guilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Van Guilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Van Guilder more than expected).
Fields of papers citing papers by Michael Van Guilder
This network shows the impact of papers produced by Michael Van Guilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Van Guilder. The network helps show where Michael Van Guilder may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Van Guilder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing Hit paper breakdown → | 2017 | 268 |
| 2 | 1993 | 113 | |
| 3 | 1998 | 107 | |
| 4 | 2009 | 91 | |
| 5 | 2015 | 54 | |
| 6 | 2016 | 52 | |
| 7 | 2014 | 51 | |
| 8 | 2000 | 47 | |
| 9 | 2000 | 40 | |
| 10 | 1989 | 22 | |
| 11 | 2004 | 12 | |
| 12 | 2014 | 6 | |
| 13 | 2021 | 3 | |
| 14 | 2008 | 2 | |
| 15 | NONLINEAR PARAMETRIC AND NONPARAMETRIC POPULATION PHARMACOKINETIC MODELING ON A SUPERCOMPUTER | 1998 | 1 |
About Michael Van Guilder
Michael Van Guilder is a scholar working on Pharmacology, Statistics and Probability, Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology, having authored 15 papers that have together received 869 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Statistical Methods and Bayesian Inference (5 papers), Statistical Methods in Clinical Trials (5 papers), Pneumonia and Respiratory Infections (3 papers), Tuberculosis Research and Epidemiology (2 papers), Pharmaceutical studies and practices (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Pharmacology (481 citations), Clinical Biochemistry (149 citations), Applied Microbiology and Biotechnology (39 citations), Infectious Diseases (334 citations) and Molecular Medicine (70 citations). Michael Van Guilder has collaborated with scholars based in United States, France and Mexico. Frequent co-authors include Alan Schumitzky, Roger W. Jelliffe, David S. Bayard, Michael Neely, Pascal Maire, Walter M. Yamada, Emi Minejima, Brenda Jones, Xavier Barbaut and Mark H. Milman. Their work appears in journals such as Therapeutic Drug Monitoring, Antimicrobial Agents and Chemotherapy, Clinical Pharmacokinetics, Statistics in Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.